FAQ
If you have any further questions, please write us here
The UroDapter can be used with syringes of Luer Lock or Luer Slip tips.
Yes, the UroDapter was designed to be effective and easy to use in both female and male patients.
Post-void residual urine should be checked only prior to the first instillation in every patient (e.g., with ultrasound). In case of no significant residual urine, further checks are not necessary prior to subsequent instillations in the same patient, unless stated otherwise in local guidelines or protocols. Patients should be simply asked to go to the restroom and empty their bladder before instillations.
Most patients do not have significant residual urine in their bladder after urination. This should be checked prior to the first instillation (e.g., with ultrasound). In patients without significant post-void residual urine, drainage of urine prior to intravesical instillations is not necessary. Patients should be simply asked to go to the restroom and empty their bladder before instillations. The minimal amount of urine still in the bladder after urination will not cause any significant dilution of the instilled solution.
The UroDapter was designed to provide a catheter-free and painless alternative for intravesical drug delivery. It is not suitable to drain urine from the bladder.
Since the UroDapter is not suitable to drain urine from the bladder, in the minority of patients with a significant post-void residual urine intravesical instillations should be performed using a standard catheter.
No. With proper use of the UroDapter, intravesical instillations can be delivered completely free of any leakage in most patients. However, - just like any other medical device - its proper use requires appropriate technique and some experience. Based on clinicians’ feedback, after performing 10 instillations in female patients, leakage occurs no more than 5% of the cases. After some further learning curve, the rate of leakage decreases to 0,5%.